AU2000272858A1 - Pharmaceutical composition for treating hyperhomocysteinaemia caused by medicaments - Google Patents
Pharmaceutical composition for treating hyperhomocysteinaemia caused by medicamentsInfo
- Publication number
- AU2000272858A1 AU2000272858A1 AU2000272858A AU7285800A AU2000272858A1 AU 2000272858 A1 AU2000272858 A1 AU 2000272858A1 AU 2000272858 A AU2000272858 A AU 2000272858A AU 7285800 A AU7285800 A AU 7285800A AU 2000272858 A1 AU2000272858 A1 AU 2000272858A1
- Authority
- AU
- Australia
- Prior art keywords
- hyperhomocysteinaemia
- medicaments
- treating
- caused
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 208000033892 Hyperhomocysteinemia Diseases 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10004651 | 2000-02-03 | ||
| DE10004651A DE10004651A1 (de) | 2000-02-03 | 2000-02-03 | Kombination von blutdrucksenkenden Wirkstoffen mit Wirkstoffen, die den Homocysteinspiegel zu senken vermögen |
| PCT/EP2000/008801 WO2001056609A1 (fr) | 2000-02-03 | 2000-09-08 | Composition pharmaceutique destinee au traitement d'une hyperhomocysteinemie provoquee par un medicament |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2000272858A1 true AU2000272858A1 (en) | 2001-08-14 |
Family
ID=7629642
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2000272858A Abandoned AU2000272858A1 (en) | 2000-02-03 | 2000-09-08 | Pharmaceutical composition for treating hyperhomocysteinaemia caused by medicaments |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU2000272858A1 (fr) |
| DE (1) | DE10004651A1 (fr) |
| WO (1) | WO2001056609A1 (fr) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7608640B2 (en) | 1999-03-02 | 2009-10-27 | Jallal Messadek | Glycine betaine and its use |
| WO2003045359A2 (fr) * | 2001-11-26 | 2003-06-05 | Astion Oncology Aps | Combinaison de derives de cimetidine et de cysteine pour traiter le cancer |
| BE1015608A6 (fr) | 2003-07-15 | 2005-06-07 | Messadek Jallal | Traitement des arterites. |
| EG24716A (en) | 2002-05-17 | 2010-06-07 | Novartis Ag | Combination of organic compounds |
| CA2534660A1 (fr) * | 2003-08-05 | 2005-02-10 | Galephar M/F | Composition pharmaceutique a unite simple comprenant un melange de fibranne et un agent reducteur d'homocysteine |
| IL157397A (en) * | 2003-08-14 | 2013-03-24 | Dpharm Ltd | Compounds, pharmaceutical compositions comprising same and uses thereof for the preparation of a medicament for the treatment of epilepsy |
| ITRM20030442A1 (it) * | 2003-09-26 | 2005-03-27 | Medosan Ind Biochimiche Riuni Te S R L | Composizione farmaceutica (stressen) per il trattamento di iperomocisteinemia. |
| AU2005262228A1 (en) * | 2004-07-09 | 2006-01-19 | Medicure International Inc. | Combination therapies employing nicotinic acid derivatives or fibric acid derivatives |
| WO2006050581A2 (fr) | 2004-11-10 | 2006-05-18 | Jallal Messadek | Betaine en tant qu'agent de lutte contre des maladies transmises par des arthropodes ou des moustiques |
| EP1681055A1 (fr) * | 2005-01-13 | 2006-07-19 | PEJO Iserlohn Heilmittel-und Diät-GmbH & Co.KG | Préparation pharmaceutique pour le traitement des taux d'homocysteine elevés |
| WO2006086856A1 (fr) | 2005-02-15 | 2006-08-24 | Messadek, Jallal | Compositions therapeutiques combinees et leurs procedes d’utilisation |
| CA2650556A1 (fr) | 2005-04-27 | 2006-11-02 | Jallal Messadek | Combinaisons insuliniques |
| CN100497337C (zh) * | 2006-11-20 | 2009-06-10 | 淮北辉克药业有限公司 | 叶酸二甲双胍及其制备方法 |
| CN103386130A (zh) * | 2013-06-27 | 2013-11-13 | 深圳奥萨医药有限公司 | Ace抑制剂/噻嗪类利尿剂/5-甲基四氢叶酸药物组合物及用途 |
| US10016379B2 (en) | 2015-10-30 | 2018-07-10 | Robin L. Webb | Method of treatment for third spacing |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6008221A (en) * | 1996-11-06 | 1999-12-28 | Bristol-Myers Squibb Company | Method for treating Alzheimer's disease with folic acid |
| WO1999044563A2 (fr) * | 1998-03-06 | 1999-09-10 | Brown Charles L Iii | Composition pour le traitement et la prevention de coronaropathie |
-
2000
- 2000-02-03 DE DE10004651A patent/DE10004651A1/de not_active Ceased
- 2000-09-08 AU AU2000272858A patent/AU2000272858A1/en not_active Abandoned
- 2000-09-08 WO PCT/EP2000/008801 patent/WO2001056609A1/fr not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001056609A1 (fr) | 2001-08-09 |
| DE10004651A1 (de) | 2001-08-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002222118A1 (en) | Pharmaceutical compositions for inhalation | |
| AU781269C (en) | Pharmaceutical compositions | |
| AU2001250420A1 (en) | Pharmaceutical compositions | |
| AU2001274307A1 (en) | Pharmaceutical compositions | |
| AU2001271037A1 (en) | Pharmaceutical compositions containing dds compounds | |
| AU2001266338A1 (en) | Pharmaceutical compositions for angiogenic therapy | |
| AU2002302147A1 (en) | Pharmaceutical composition | |
| AU2000272858A1 (en) | Pharmaceutical composition for treating hyperhomocysteinaemia caused by medicaments | |
| AU2001290239A1 (en) | Medicinal composition | |
| AU2002221115A1 (en) | Medicinal compositions having improved absorbability | |
| HUP0401612A3 (en) | Pharmaceutical composition suitable for treating diabetes | |
| AU2001273919A1 (en) | Pharmaceutical compositions | |
| AU2002215114A1 (en) | Pharmaceutical compositions for inhalation | |
| AU3945501A (en) | Apparatus for dosage of medicaments | |
| AU2002306687A1 (en) | Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them | |
| AU4085201A (en) | Pharmaceutical composition | |
| AU3586401A (en) | Pharmaceutical composition | |
| AU2001292578A1 (en) | Pharmaceutical compounds | |
| AU2882699A (en) | Stabilizing composition for pharmaceutical dosage forms | |
| AU2001278705A1 (en) | Pharmaceutical composition | |
| AU2002331279A1 (en) | Pharmaceutical composition for treating hypercholesterolaemia | |
| HU9902296D0 (en) | Pharmaceutical composition for treating caltification | |
| AU4698900A (en) | Pharmaceutical compositions for treating malaria | |
| AUPR529701A0 (en) | Pharmaceutical composition | |
| AU2003252701A1 (en) | Medicinal composition for treating thrombopenia |